Research, Science, and Technology
Santa Fe has some very bright and talented medical professionals providing care in our beautiful community. Our practice, however, goes to the next level and includes research and advanced studies in technology.
Our philosophy is one of putting our patient's needs first. We're the only Family Practice, in Santa Fe, open Monday through Friday from 12 noon until 8 p.m. to care for people who work for a living, and for our retired community as well. We're also the only Family Practice open on Saturdays from 9 a.m. until 5 p.m.
While our practice experiences consistent growth, our primary consideration is and will remain our patient's needs. We provide for our patient's needs each day using the latest tools and technologies available. We also realize we have an overriding responsibility and need to work with some of the brightest minds in science to help humankind to develop additional new evaluation technologies and treatments to prevent human suffering and to aid in human longevity, and to improve the quality of that life.
Our medical director, Robert Walantas, as been elected to the Board of Directors for Vista Therapeutics, the largest and most talented nano-technology company in New Mexico. Headed by leading researcher and (retired MIT and Harvard staff) scientist Dr Spencer Farr, Vista has developed, and is commercializing the 'nano-bio-sensor' and the 'nano-pharma-sensor'.
Nano-Tech Destroys Breast Cancer!
Researchers at the University of Georgia are developing a new treatment technique that uses nanoparticles to reprogram immune cells so they are able to recognize and attack cancer. The findings
were published recently in the early online edition of ACS Nano.
The human body operates under a constant state of martial law. Chief among the enforcers charged with maintaining order is the immune system, a complex network that seeks out and destroys the hordes of invading bacteria and viruses that threaten the organic society as it goes about its work.
The immune system is good at its job, but it's not perfect. Most cancerous cells, for example, are able to avoid detection by the immune system because they so closely resemble normal cells, leaving the cancerous cells free to multiply and grow into life-threatening tumors while the body's only protectors remain unaware.
Shanta Dhar and her colleagues are giving the immune system a boost through their research.
"What we are working on is specifically geared toward breast cancer," said Dhar, the study's co-author and an assistant professor of chemistry in the UGA Franklin College of Arts and Sciences. "Our paper reports for the first time that we can stimulate the immune system against breast cancer cells using mitochondria-targeted nanoparticles and light using a novel pathway."
In their experiments, Dhar and her colleagues exposed cancer cells in a petri dish to specially designed nanoparticles 1,000 times finer than the width of a human hair. The nanoparticles invade the cell and penetrate the mitochondria—the organelles responsible for producing the energy a cell needs to grow and replicate.
They then activated the nanoparticles inside the cancer cells by exposing them to a tissue-penetrating long wavelength laser light. Once activated, the nanoparticles disrupt the cancer cell's normal processes, eventually leading to its death.
The dead cancer cells were collected and exposed to dendritic cells, one of the core components of the human immune system. What the researchers saw was remarkable.
"We are able to potentially overcome some of the traditional drawbacks to today's dendritic cell immunotherapy," said Sean Marrache, a graduate student in Dhar's lab. "By targeting nanoparticles to the mitochondria of cancer cells and exposing dendritic cells to these activated cancer cells, we found that the dendritic cells produced a high concentration of chemical signals that they normally don't produce, and these signals have traditionally been integral to producing effective immune stimulation."
Dhar added that the "dendritic cells recognized the cancer as something foreign and began to produce high levels of interferon-gamma, which alerts the rest of the immune system to a foreign presence and signals it to attack. We basically used the cancer against itself."
She cautions that the results are preliminary, and the approach works only with certain forms of breast cancer. But if researchers can refine the process, this technology may one day serve as the foundation for a new cancer vaccine used to both prevent and treat disease.
"We particularly hope this technique could help patients with advanced metastatic disease that has spread to other parts of the body," said Dhar, who also is a member of the UGA Nanoscale Science and Engineering Center, Cancer Center and Center for Drug Discovery.
If the process were to become a treatment, doctors could biopsy a tumor from the patient and kill the cancerous cells with nanoparticles. They could then produce activated dendritic cells in bulk quantities in the lab under controlled conditions before the cells were injected into the patient.
Once in the bloodstream, the newly activated cells would alert the immune system to the cancer's presence and destroy it.
"These are the things we can now do with nanotechnology," Dhar said. "If we can refine the process further, we may be able to use similar techniques against other forms of cancer as well."
Explore further:Modified immune cells seek and destroy melanoma
More information: pubs.acs.org/doi/ipdf/10.1021/nn403158n
Journal reference:ACS Nano
Nanotechnology and the Nano-Bio-Sensor
Before we get to the question of what a nano-bio-sensor is, let's get to a working definition of Nanotechnology. Nanotechnology is the "intentional design, characterization, production, and applications of materials, structures, devices, and systems by controlling their size and shape in the nanoscale range (1 to 100 nanometers)".
There are 25.4 millimeters in an inch. There are 39.37 inches in a meter (right at 3.37 inches longer than a yard stick). A millimeter is 1/1,000 of a meter. A nanometer is one billionth of a meter or 1/1,000,000,000 of a meter. Because Nanomaterials are similar in scale and shape to biologic molecules and systems, yet they can be engineered to have various functions and controlling factors: nanotechnology is highly fitted to become an entire next generation (or 3 or 4 generations) in biologic and medical science.
So, what's a nano-bio-sensor? A nano-bio-sensor is a double fist sized nano-tech device which can measure 300 substances in real time, (to do this now would consume about 5 floors of lab equipment and several dozen workers in a research hospital, and would not occur in 'real-time'). Most importantly, the nano-bio-sensor can detect all of the various components (about 18) in the 'infalmmatory cascade', as well as all of the components in the 'healing cascade'. The 'inflammatory cascade' is what the body 'activates' when it's injured or ill. When elements in the cascade run 'wild' they can kill a person who'd otherwise survive the injury or illness. This running 'wild' of a protective system occurs very often, all too often. The 'healing cascade' is what we want to enhance to improve healing and to prevent suffering.
Up until this point, the only way to measure the components in the inflammatory cascade was to take a blood sample, send it off to a 'research' facility, pay about a fifteen hundred dollars and wait two weeks for the results to be sent. In the meantime the patient died!
With the Vista nano-bio-sensor, for the first time ever, samples of blood can be evaluated in real time and checked for everything from changes in blood glucose to the status of the various elements of the inflammatory or healing cascades.
More importantly, in the short term, are the many pharmaceutical, nano-tech, bio-tech, and other research companies, who, for the first time can measure the reaction to an injury or illness. Scientists will be able to calculate exactly what factors trigger the 'over reaction' and can next develop technologies which can tamp this down to a 'normal' or 'healthy' reaction.
There will be scientific developments which will result in: reducing human suffering; making injuries that would not heal- to now heal; and allowing many who would needlessly suffer and die, to not suffer and to not die! The staff and directors at Vista Therapeutics will usher in new developments in medicine, in dentistry, and in veterinary medicine. And, since Dr Farr and his extensive network of professional associates and advisors have made this development, you can bet they also have some very specific ideas in how to correct certain disruptive factors in the inflammatory cascade as well as ways to enhance the healing cascade!
What the Vista Therapeutics team has done is not just brilliant, it's going to vault forward medical science by about 3 or 4 generations. There are critical developments in nano-science which need to occur, however, they've been delayed by the inability to prove, in real time, what they do and how they work. Read on about some very interesting developments!
The nano-pharma-sensor is a 1/4 inch, or smaller, device which can fit into a 'desk-top' model, or into a watch like device. The nano-pharma-sensor can detect any drug or pharmaceutical substance a person has taken or put into or onto their body. Let's look at some examples where the nano-pharma-sensor would help:
Would it be 'good' to know if a pharmacist, or a truck driver, who has very high blood presure, has remembered to take their blood presure medication? If they have, then their usual 210/110 extremely high blood pressure number will be closer to 120/70, and they'll be more likely to safely do their work today, rather than have a stroke or heart attack.
Would it be 'good' to know if that same pharmacist or truck driver has taken crystal meth today? How about Cocaine? Heroin? That's right: the nano-pharma-sensor can help insure people safely take medications they need to take, and the sensor can even be programmed to remind the user when to take their medication. The nano-pharma-sensor will also warn when people in important positions have dangerous drugs in their systems.
It's easy to see why the team at Vista Therapeutics sees the nano-pharma-sensor system as a win-win for everyone!
Turning OFF MicroRNA (miR-21) Gene Cures Lymphoma
From the Journal Nature, September 2010: Controlling a single gene, MircoRNA-21 (miR-21), in mice, has proven critical in stopping the invasion and destruction of the lymph system, the bone marrow, and the nervous systems.
miR-21 is a key 'oncogene', or a gene scientists have suspected for years as causing cancer to occur. In this mouse model of study, every mouse who had their miR-21 gene 'turned on' and left 'on' developed classic system wide destruction and death 100% of the time; whereas in mice who had the gene turned 'off', or those who had it turned 'on', and then turned 'off' failed to develop the cancer and die.
More promising, those mice with an 'on' miR-21, who had the gene turned 'off' had their organ systems return to normal, preinjury state. Turning 'off' a single gene has been the dream of scientists for years. In lymphoma, this has been proven in the mouse model. Soon, other animal model testing will occur, to be rapidly followed by human trials.
This study shows very good outcomes for the coming new year, especially for people with a family history of lymphoma!. It's also a shining light of hope for identification of 'oncogenes' which have been implicated in other cancers for several years. With continued research, within the decade, many cancers should be cured, and better yet, prevented! Scientific developments remain a bright arena in our economy and in our world! Things are looking up-- it's going to be a GREAT year!
Nanoparticles, MicroRNA (miR-132) and Treating Cancer
In a study, published in Nature Medicine, from August 2010: Most tumors stimulate blood vessel growth, which in turn, causes a greater blood supply to the tumor and greater tumor growth. Currently, 'angiogenesis inhibitors' are used, with less than ideal results, in reducing blood vessel growth. This is a HUGE issue in breast cancer!
A group of researchers from California and Michigan reported that a microRNA called miR-132 enhances endothelial generation of tubes (cells lining the interior part of a blood vessel) which are the essential elements needed for new vessel growth. miR-132 was found at very high levels in the endothelial cells of tumors, and it was not detected in normal vessels!
The group then engineered nanoparticles that contained miR-132 inhibitors, and attached them to a specific molecule on the miR-132 surface. The nanoparticles prevented angiogenesis (new blood vessel creation), and lowered tumor burden in a mouse model for breast cancer!
As we've said, and will continue to share with our patients at Adobe: the next BIG thing in medicine, and the next, and the next is going to be small- nanoparticle small! We'll document for you a number of studies over the coming years of nano-technology breakthroughs which will be one of the brightest spots in medical history!
You are a guest at a table, learning of the greatest scientific breakthroughs of all time. Firmly, we have no doubt that within 7 years, using nano-technology, the clearing of HIV from a person will occur with nano-tech. HIV will no longer be spread, using nano-technology!
During that same 7 year timeframe, new nano-bio-tech particles will be created, and will interface at the level of primary care, in treating severely resistant bacteria. Our office will be at the front of using these beneficial technologies. Within 10 years, using applied nano-science, we should be able to cure cancer. All of these breakthroughs are in the near future. While the economy could be doing better, nano-tech will help to grow the economy out of this slump, and to a sustained level of scientific development- and will codify scientific breakthroughs using collabotation at major research facilities and universities throughout the world to vastly improve human health and longevity!
This is a wonderful period of time to be alive. And...you have a front row seat!
Nanoparticles, MicroRNA and Treating Prostate Cancer
From the Advanced Practitioner in Oncology, Jan/Feb 2011, new Biomarkers are being identified in prostate cancer detection. The 'scientific discussion' is ongoing that PSA, while it's helped many people identify prostate cancer early, and receive treatment, it's also caused many people with 'chronic prostatitis' (chronic bacterial prostate infections which can get 'better' but which never resolve), or 'other' prostate conditions to be 'evaluated' and biopsied multiple times with 'normal' findings from multiple painful and expensive biopsy tests.
The pendulum of thought has swung from do a PSA test on nearly 'everyone' and test early, to a 'less than wisely informed' recommendation to test nearly 'no one' . The 'leading' force against nearly all preventive testing, as not 'cost effective' is the U.S. Preventive Services Task Force (USPSTF). The U.S. Centers for Disease Control has taken and parroted the USPSTF position- not that it took alot of brain power to parrot the USPSTF.
At this point, only the Amercian Cancer Society continues to have a reasonable testing procedure recommendation which looks at family history, personal symptoms, and a number of important and relevant factors. What's sad, is that ALL professional groups concur that testing and treatment of prostate cancer has saved lives.
One of the key points of contention is the inaccuracy of the PSA test. At the time it arrived, the PSA test was the best test available, versus 'no test' and a digital rectal exam. There are currently two 'new' tests available: TMPRSS2-ERG and PCA3. Both of these 'new' tests are more specific than PSA and appear more accurate at identification of more aggressive disease. Sounds good, but these two both have some 'accuracy' issues, which will cause 'reliability' issues and eventually non-use of these tests.
Certain universities are studying the use of microRNA's in identification of Prostate Cancer. Since miRNA's patterns are very different in normal versus cancerous cells, as with our two studies (above), miRNA will soon become the dominant research subject. We have no doubt, that within 18 to 24 months, the specific miRNA will be identified, and initially tested in the mouse model.
Based on prior testing, we firmly believe the miRNA therapy will direct specific nano-particle therapy, and this therapy will be several generations ahead of current therapy, where sometimes the patient is killed or nearly killed, while using surgery, radiation and chemotherapy to kill and destroy healthy and cancerous tissue.
While some of what 'Oncologists' appear to be doing is seen as barbaric and harmful: they are using the best tools available. What this group of caring and dedicated health care providers need are better detection tools and better treatment tools. The identification and use of miRNA testing and nano-bio-technology will vault medical science 3 to 4 'generations' ahead of current practice.
Take Home Message: Despite what seems like 'leaders who won't lead' from the USPSTF and CDC, we need to keep a positive focus and use our frustration with current testing to find the most acurate testing which matches up with the most effective treatments ever discovered: miRNA and nano-bio-technology. In the two nano-bio-science articles, above, we have no doubt we have some of the brightest minds who've found solutions and effective detection systems. Soon, those with prostate 'problems' or a family history of prostate cancer, will have the most effective detection and treatment methods ever available. Nano-bio-science: while it deals with the smallest particles, it will vault medical science ahead by 3 to 4 generations! We feel honored to have a front row seat in the development of nano-bio-science!
Deadly Superbugs Coming to the U.S.
From an article in The New England Journal of Medicine, December 16th 2010: Research scientists, working at the world's largest drug companies, with combined multi-billion dollar research budgets, have discovered a new group of emerging 'Super Bugs', that are resistant to every antibiotic, except one.
Unfortunately, the drug companies have NOTHING in the pipeline, and lack the ability to create a new generation of 'super-anti-biotics' to treat the new 'super-bugs' and to prevent a major world-wide bacterial epidemic. That the companies are not working on finding new antibiotics has to do with their success (read failure) over the past ten years. Within the first 6 months of the launch of a 'new' antibiotic, they've found a large number of resistant bacteria to the new antibiotic. Calculated out, the new super bugs could beat out the 'time to discover' new antibiotics, and they would fail to remain effective. The drug companies have done their best for decades, but have now lost. For humankind: this is a VERY desperate and a VERY frustrating situation. But that's a good thing!
Understand: bacteria reproduce every 20 minutes (72 times a day). 'Bad' Bacteria share genetic material with other 'bad' bacteria, and while we humans are largely bacteria and water (based upon weight), those bacteria that we're mostly composed of are 'our' healthy bacteria which aid with digestion and other 'normal' body functions, and help fight off 'bad' bacteria in our systems. So how's this bacterial 'epidemic' good?
NDM-1 is a cause for WORLWIDE concern. Never heard of it? Then let's say it again: NDM-1 is a WORLDWIDE concern for major epidemics which could kill HUNRDEDS of MILLIONS of people on every continent! NDM-1 stands for New Delhi metallo-beta-lactamase 1, and refers (now) not just to one bacterial species, but to a transmissible genetic element encoding multiple resistance genes that was initially isolated from a strain of Klebsiella (bacteria), obtained from a patient who acquired the organism in New Dehli, India, that had caused him a urinary tract infection (UTI).
Organisms, from the Enterobacteria family, containing this genetic element (or variants of this element) have been found throughout India, Pakistan, and Bangledesh, and are currently showing up in Great Birtain, and, soon, will be in countries throughout the world. Every antibiotic, except one, is unsccesful in treating NDM-1.
In the near future, unless we can find a major new treatment, or a new type of technology for treating bacterial infection, then, when a woman, in the US, gets a UTI (which happens several MILLION times a year): it'll no longer be treatable with one of several antibiotics. That infection will go from her bladder, up her ureters, into her kidneys, then into her blood stream, then this woman will become septic, and will be dead, all within a week! In the meantime, she'll be shedding bacteria into the general environment, to 'share' with us.
Have a child with a Strep throat? We'd usually give one of several antibiotics: those will fail to work too, if we fail to change the future. Your child will have the Strep go from their throat, into their blood stream, to their kidneys, to their heart, to their spine, and brain, and, again, in less than a week- they'll be dead!
Fifty years ago, there were articles, in medical journals, describing a similar worry of resistant bacteria, however, the drug companies came up with new anti-biotic drugs. These same drug companies, today, have used every 'tool' in their tool chest in developing anti-biotics. Bacteria have become more resistant over the decades. This is not a critique of the drug companies: it's merely an admission they have no more 'new' tools or developments to treat new generations of progressively more deadly and resistant bacteria. The key point here is: science's 'usual' way of defeating life-threatening bacteria needs to change. That's the challenging, and the best part.
In the article below, you'll see, where we have associates, in Toronto, Canada, who are on the verge of performing human studies which could eliminate HIV! Herein is the large hope for the future: Much of the science of nano-bio-technology, which was applied to finding the 'viral treatment and cure' (for HIV) can be applied to other viral and bacterial infections.
Better yet, much of the nano-science which will evolve, from these infectious research studies, has the potential to guide us on a secure path to eliminate cancers. Having listened to biologists and scientists, from a number of fields, for the past 2 decades, nearly every missing piece of the puzzle, which was needed to solve a scientific problem, can now be solved by nano-bio-science.
Our group of local nano-science leaders is actively working to evolve small networks of nano-scientists, throughout the world, devoted to working on specific human problems. There are planned: specific viral infectious working groups; bacterial infectious working groups; a group working on removing plaques in arteries (preventing and treating heart attack and stroke); another team regenerating blood vessels and turning on genes to regrow healthy cardiac tissue, after a heart attack; and a program group to treat and resolve certain cancers. Another work-group is to find treatments for Parkinson's and Alzheimer's.
While each of the working groups focuses upon their particular task, it's already known that many problems which one group solves will supply information and techniques which will apply to problems another group is working on. This means that instead of 3 years for resolution to a particular health problem: we're looking at months. Sharing was nice in kindergarten- it's also nice in nano-bio-technology!
The difference in all of the new science, is with nano-scale projects, we have genetic level material to work with, which will perform many of the 'wish list' tasks which scientists have had for years, in wanting to treat various conditions, but they lacked the tools. As many thousands of nano 'tools' presently exist, there are millions that can yet be built. The more we learn of our nano-technology tools, what all they can do, and the benefits they could provide humankind, we realize there are millions of variations more we could produce. Actually, enough for a few 'super computers' to calculate.
While NDM-1 is a reasonable cause for concern, it is out of our collective frustration, and inability to treat current problems, that causes humans to evolve and to adapt science to develop new techniques and new technologies! The development of nano-technology and nano-bio-technology will advance medical science about 3 to 4 generations from our present day! NDM-1 is not our 'friend', but it's a very real threat that will help prod many scientists to work together, rapidly, to evolve a whole new science in eliminating biological threats, and to develop even more technologies to treat threats, which for centuries, have eluded science!
Supercomputers can image a virus or bacterial particle in 3-D, which can calculate which 'tools' the bacteria is using to enter human bodies, cells, and cell structures, and what it's doing to defeat our 'natural' defenses. The supercomputer would interface with calculated nano-bio models, and then then calculate out several nano-bio-devices which could be deployed into people to serve as scouts, and form an attack force (like a vaccine), or develop others which could assemble a potent destructive force, and once their work is done, to disassemble and use natural pathways to elimate themselves.
These techniques and technologies are similar to 'Star Trek' or 'Star Wars' in how those futuristic, scientific, advanced societies used computers and technology to create nano-particles and nano-devices, at rapid speed, which served humankind, and defeated infections or solved injuries. The future is becoming now. And now is a good time to be alive!
For Decades: The Next Big Development in Medicine is Small
Nanotechnology is the "intentional design, characterization, production, and applications of materials, structures, devices, and systems by controlling their size and shape in the nanoscale range (1 to 100 nanometers)". Because Nanomaterials are similar in scale and shape to biologic molecules and systems, yet they can be engineered to have various functions and controlling factors: nanotechnology is highly fitted to become an entire next generation (or 3 or 4 generations) in biologic and medical science.
Taken from an article in the New England Journal of Medicine, December 16th 2010, we'll review the 'small' yet massive development in nanotechnology, so the reader may see and anticipate several future postings on such major nano developments which will redefine medicine, science, and our capacity to improve and extend life and quality of life.
One of humankind's greatest plagues, for now, is HIV. There are other health problems, but understanding, and conquering HIV will lead to generations of breakthrough science for decades!
Dendrimers, which are nanostructures that look like tree branches, have prevented the transmission of HIV in Macaque Monkeys, (1 step below humans in treatment). How the inhibition of growth and transmission disruuption occurs, depends upon the dendrimer's surface chemical features and size.
For example, dendrimers with benzene dicarboxylate on the surface inhibit HIV from entering the cell of the host, by binding to it's viral capsid. Dendrimers with napthalene disulfonate on the surface, enter cells and inhibit reverse-transcriptase and integrase activity. Exactly why these mechanisms work as well, and repeatedly as well as they do, has yet to be proven to the depth required by science, and is currently under investigation.
The two enzymes mentioned above (reverse-transcriptase and integrase) are involved in translating HIV viral RNA into host DNA. So far, it's believed the dendrimer size mimics the ligand, whereas the mulitvalency stregthens the interaction with the biologic target. In both cases, the therapeutic benefit for the host persists: the virus can not function normally, cannot be transmitted from one Macaque monkey to another, and the virus can not invade new cells in the existing host. Since nearly every healthy cell in a body will reproduce every 90 days, with the old cells dying, we can use multiples of time to free a host from HIV infection!
Nanoscience is using nanobots, or therapies, once in this case, and ridding the body of HIV and preventing transmission- the two key functions which no HIV medication has done, or could ever do, with current technology. This is why we say, Nanotechnology will take us several generations ahead of where current medical science is at: taking us from stalling death in HIV, to ridding the body of HIV for good, while, at the same time preventing the HIV transmission!
The next big development (and the next) in medicine is going to be small: nano-scale small, and the benefit for humankind will be massive!
What About 'Dangerous' Uses of Nano-Technology
Unfortunately, this is a relevant and important qustion. With great power, and great technology, great good can happen with nano-tachnology; also great evil can occur.
Certain research companies have a clear understanding, that while intentions, skills, and security systems are intended to benefit humankind, there could, and do exist, groups who could attempt to use nano-science to cause, not just harm, but massive harm.
Because researchers realize not everyone is 'nice', they have planned for the worse. That means they have a 'Black Hat' arm to their organizations which will plan out a variety of harmful events using nano-bio-science. A 'White Hat' team will work to resolve every possible way to beat out the 'Black Hats', and have the benefit of supercomputers to speed the process. Of course, all of this happens behind a curtain of secrecy. This 'exercise' seems to be a 'waste of time and resources' until a 'bad event' happens.
When our government (and our citizens) come up aganist a 'bad event', they'll want an immediate, effective answer. Using 'black hat/white hat' operations, researchers will have 'answers' already in place. The side-effect of such activities: new discoveries are made, or new methods developed to solve current problems.
It's comforting to know that scientists are working to solve humankind's major health problems, and with new nano-tech tools, there's a redundant matrix to identify and to help solve potential 'new' problems such technology could create in the 'wrong hands'. Having such understanding should help each person sleep better at night. In short, humankind will benefit from the resolution of many current and future health problems, while keeping the world safe from people with less than honorable intentions.
The Common Cold: If We Can Kill It, Should We?
That's one busy, ethical problem: simply because we have the ability to do something should we? One analogy would be: simply because we have a loaded .357 handgun, and can pull the trigger 6 times, aiming in any direction, should we?
Most reasonable people would say, NO! You could hurt, harm, or kill an innocent person. Now, place that same loaded .357, aimed at an intruder who says he's going to kill you and your family. You now have a very different answer: shoot directly and precisely until he stops moving and is not just dead, but very dead.
A similar question arises when a new, powerful technology, such as nano-technology, and nano-bio-technology arrives. Simply because we can 'cure' the common cold, should we? We believe the answer is a firm: NO!
While the 'offending virus' can cause a person to feel ill and tired, have a runny nose, and a cough that keeps them awake at night, that's a far cry from serious injury or death. We know, from other studies, that when we work 'with' healthy bacteria, which the body likes to carry around (Pro-Biotics), we have an 85% reduction in all colds and all flu illnesses. Eighty-five percent is fairly good, and most important, it indicates a stregthening of a person's natural immune system: that's a hugely positive event!
It's crucial we continue to expose our immune systems to a variety of bothersome bacteria and viruses to maintain a healthy anti-body state to our immune system. What nano-bio-technology does is to augment, to work with the body's immune system, not take its' place. Who needs a 'cure' when we already have a treatment that works 85% of the time, and it's one that helps stregthen our immune system!